LONDON/NEW YORK (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for electronic ...
Shares in Misys leap as much as 26 percent to a 6-1/2-year high after the IT firm says it will sell the majority of its Allscripts healthcare IT subsidiary, which is merging with rival Eclipsys , and ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する